カテゴリ： Research Dive, 世界, 医療/バイオ

気道管理デバイスのグローバル市場2022-2031：声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他

■ 英語タイトル：Airway Management Devices Market by Device Type (Infraglottic Devices, Supraglottic Devices, Laryngoscopes, Resuscitators, and Others), Patient Age (Adult Patients and Pediatric Patients), and End User (Hospitals, Ambulatory Care, Home Care, and Others): Global Opportunity Analysis and Industry Forecast 2022–2031

調査会社Research Dive社が発行したリサーチレポート（データ管理コード：RDV23MA012）■ 発行会社/調査会社：Research Dive
■ 商品コード：RDV23MA012
■ 発行日：2022年12月13日
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：250
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[気道管理デバイスのグローバル市場2022-2031：声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Research Dive社によると、世界の気道管理デバイス市場規模は2021年1,961.50百万ドルから2031年には4,182.20ドルまで、年平均7.7%の成長率を表すと見込まれます。本レポートでは、気道管理デバイスの世界市場を調査・分析し、調査手法、調査範囲、エグゼクティブサマリー、市場概要、デバイス種類別（声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他）分析、患者年齢別（成人患者、小児患者）分析、エンドユーザー別（病院、外来治療、在宅ケア、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況など、以下のようにまとめました。本書の参入企業情報としては、Medtronic, Smiths Medical, Inc., Teleflex Incorporated., KARL STORZ SE & Co. KG, Ambu A/S., Flexicare (Group) Limited, Intersurgical Ltd, SunMed, VYAIRE MEDICAL, INC., and Vbm Medizintechnik.などがあります。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の気道管理デバイス市場規模：デバイス種類別
- 声門下デバイスの市場規模
- 声門上デバイスの市場規模
- 喉頭鏡の市場規模
- 蘇生器の市場規模
- その他デバイスの市場規模
・世界の気道管理デバイス市場規模：患者年齢別
- 成人患者における市場規模
- 小児患者における市場規模
・世界の気道管理デバイス市場規模：エンドユーザー別
- 病院における市場規模
- 外来治療における市場規模
- 在宅ケアにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の気道管理デバイス市場規模：地域別
- 北米の気道管理デバイス市場規模
- ヨーロッパの気道管理デバイス市場規模
- アジア太平洋の気道管理デバイス市場規模
- 中南米の気道管理デバイス市場規模
- 中東/アフリカの気道管理デバイス市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global airway management devices market is anticipated to generate a revenue of $4,182.20 million by 2031, increasing from $1,961.50 million in 2021, at a CAGR of 7.7%.

COVID-19 Impact on the Global Airway Management Devices Market:
COVID-19 has positively impacted various industries such as the medical sector that has led to a drastic increase in medicines sales. As airway management devices are widely used to alleviate upper airway obstruction caused by tonsillar or adenoidal hypertrophy, or normal pharyngeal tissue obstruction, there was a significant rise in the airway management device demand globally. The COVID-19 pandemic has caused a spike in the number of patients being admitted to ICUs and emergency rooms. Patients with severe infections frequently need ventilators and other positive air pressure devices to treat respiratory failure or low oxygen saturation. Therefore, there is a higher need for airway management devices, particularly single-use ones. The number of patients who require intubation using invasive airway management techniques has increased due to the possibility of virus particles being aerosolized during non-invasive procedures. The market for airway management devices has expanded owing to the high risk faced by healthcare professionals providing airway management treatment to COVID-19 patients and other patients throughout healthcare institutions.

Various initiatives taken by companies to support airway management device projects are helping society to recover from the pandemic. For instance, on January 6, 2022, ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L). The Smiths Medical business includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the acquired companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.

Airway Management Devices Market Analysis:
The market has also been impacted by the increase in funds provided by the federal government to promote the adoption of airway management medical devices. The market for airway management devices also benefits from the rise in healthcare spending, improvements in the healthcare infrastructure, and a strong need for extended care delivery. Furthermore, airway difficulties in patients with cardiac, infectious, or chronic illnesses typically require prompt medical attention. A fast airway clearance may also be necessary to protect the safety of victims of car accidents or other traumatic injuries. The demand for airway management devices is rising globally owing to the increase in the prevalence of chronic respiratory diseases.
As the number of airway management devices increases, airway management is expected to become more complicated and limited due to factors such as intubation and others. Although endotracheal intubation is one of the most often used methods, employing it comes with risks and difficulties. Most underdeveloped countries have low adoption rates for pricey airway management devices due to their ineffective reimbursement policies or lack of public health insurance. All these factors are anticipated to restrain the airway management devices market demand during the forecast period.
Patients with COVID-19 who need ventilation are frequently intubated using single-use tracheostomy or endotracheal tubes. The market for airway management devices has increased globally as a result of the rise in the prevalence of COVID-19. Furthermore, technological advances are also encouraging major players to seek strategic agreements in order to grow quickly. This is projected to expand the market for airway management devices in the future. All these aspects are predicted to boost the airway management devices market size in the upcoming years.

Based on devices type, the infraglottic devices sub-segment is predicted to show the fastest growth rate by 2031. A small incision is made at the base of the glottis in the trachea and an infra-glottic airway device is introduced into it for ventilation and airway management. Tracheostomy tubes and endotracheal tubes are two further divisions of infraglottic devices.
Based on patient age, the adult patients sub-segment accounted for the most dominant sub-segment in 2021. The main drivers of the adult patients segment include the increase in the aging population and the rise in chronic diseases in elderly patients.
Based on end user, the hospitals sub-segment accounted for the most dominant sub-segment in 2021, due to the growing use of airway management devices in the healthcare industry.
Based on geographical scope, the Asia-Pacific airway management devices market is anticipated to show the fastest growth by 2031. The regional airway management market is expected to witness the quickest growth due to an increase in public knowledge of technology breakthroughs and airway management applications.
The companies involved in the global airway management devices market are Medtronic, Smiths Medical, Inc., Teleflex Incorporated., KARL STORZ SE & Co. KG, Ambu A/S., Flexicare (Group) Limited, Intersurgical Ltd, SunMed, VYAIRE MEDICAL, INC., and Vbm Medizintechnik.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global Airway Management Devices market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on Airway Management Devices market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Airway Management Devices Market Analysis, by Device Type

5.1.Overview
5.2.Infraglottic Devices

5.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031

5.3.Supraglottic Devices

5.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031

5.4.Laryngoscopes

5.4.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.4.2.Market size analysis, by region, 2021-2031
5.4.3.Market share analysis, by country, 2021-2031

5.5.Resuscitators

5.5.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.5.2.Market size analysis, by region, 2021-2031
5.5.3.Market share analysis, by country, 2021-2031

5.6.others

5.6.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.6.2.Market size analysis, by region, 2021-2031
5.6.3.Market share analysis, by country, 2021-2031

5.7.Research Dive Exclusive Insights

5.7.1.Market attractiveness, 2021-2031
5.7.2.Competition heatmap, 2021-2031

6.Airway Management Devices Market, by Patient Age

6.1.Adult Patients

6.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
6.1.2.Market size analysis, by region, 2021-2031
6.1.3.Market share analysis, by country, 2021-2031

6.2.Pediatric Patients

6.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
6.2.2.Market size analysis, by region, 2021-2031
6.2.3.Market share analysis, by country, 2021-2031

6.3.Research Dive Exclusive Insights

6.3.1.Market attractiveness, 2021-2031
6.3.2.Competition heatmap, 2021-2031

7.Airway Management Devices Market Analysis, by End User

7.1.Hospitals

7.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.1.2.Market size analysis, by region, 2021-2031
7.1.3.Market share analysis, by country, 2021-2031

7.2.Ambulatory Care

7.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.2.2.Market size analysis, by region, 2021-2031
7.2.3.Market share analysis, by country, 2021-2031

7.3.Home Care

7.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.3.2.Market size analysis, by region, 2021-2031
7.3.3.Market share analysis, by country, 2021-2031

7.4.Others

7.4.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.4.2.Market size analysis, by region, 2021-2031
7.4.3.Market share analysis, by country, 2021-2031

7.5.Research Dive Exclusive Insights

7.5.1.Market attractiveness, 2021-2031
7.5.2.Competition heatmap, 2021-2031

8.Airway Management Devices Market, by Region

8.1.North America

8.1.1.U.S.

8.1.1.1.Market size analysis, by Device Type, 2021-2031
8.1.1.2.Market size analysis, by Patient Age, 2021-2031
8.1.1.3.Market size analysis, by End User, 2021-2031

8.1.2.Canada

8.1.2.1.Market size analysis, by Device Type, 2021-2031
8.1.2.2.Market size analysis, by Patient Age, 2021-2031
8.1.2.3.Market size analysis, by End User, 2021-2031

8.1.3.Mexico

8.1.3.1.Market size analysis, by Device Type, 2021-2031
8.1.3.2.Market size analysis, by Patient Age, 2021-2031
8.1.3.3.Market size analysis, by End User, 2021-2031

8.1.4.Research Dive Exclusive Insights

8.1.4.1.Market attractiveness, 2021-2031
8.1.4.2.Competition heatmap, 2021-2031

8.2.Europe

8.2.1.Germany , 2021-2031

8.2.1.1.Market size analysis, by Device Type, 2021-2031
8.2.1.2.Market size analysis, by Patient Age, 2021-2031
8.2.1.3.Market size analysis, by End User, 2021-2031

8.2.2.UK

8.2.2.1.Market size analysis, by Device Type, 2021-2031
8.2.2.2.Market size analysis, by Patient Age, 2021-2031
8.2.2.3.Market size analysis, by End User, 2021-2031

8.2.3.France

8.2.3.1.Market size analysis, by Device Type, 2021-2031
8.2.3.2.Market size analysis, by Patient Age, 2021-2031
8.2.3.3.Market size analysis, by End User, 2021-2031

8.2.4.Spain

8.2.4.1.Market size analysis, by Device Type, 2021-2031
8.2.4.2.Market size analysis, by Patient Age, 2021-2031
8.2.4.3.Market size analysis, by End User, 2021-2031

8.2.5.Italy

8.2.5.1.Market size analysis, by Device Type, 2021-2031
8.2.5.2.Market size analysis, by Patient Age, 2021-2031
8.2.5.3.Market size analysis, by End User, 2021-2031

8.2.6.Rest of Europe

8.2.6.1.Market size analysis, by Device Type, 2021-2031
8.2.6.2.Market size analysis, by Patient Age, 2021-2031
8.2.6.3.Market size analysis, by End User, 2021-2031

8.2.7.Research Dive Exclusive Insights

8.2.7.1.Market attractiveness, 2021-2031
8.2.7.2.Competition heatmap, 2021-2031

8.3.Asia-Pacific

8.3.1.China

8.3.1.1.Market size analysis, by Device Type, 2021-2031
8.3.1.2.Market size analysis, by Patient Age, 2021-2031
8.3.1.3.Market size analysis, by End User, 2021-2031

8.3.2.Japan

8.3.2.1.Market size analysis, by Device Type, 2021-2031
8.3.2.2.Market size analysis, by Patient Age, 2021-2031
8.3.2.3.Market size analysis, by End User, 2021-2031

8.3.3.India

8.3.3.1.Market size analysis, by Device Type, 2021-2031
8.3.3.2.Market size analysis, by Patient Age, 2021-2031
8.3.3.3.Market size analysis, by End User, 2021-2031

8.3.4.Australia

8.3.4.1.Market size analysis, by Device Type, 2021-2031
8.3.4.2.Market size analysis, by Patient Age, 2021-2031
8.3.4.3.Market size analysis, by End User, 2021-2031

8.3.5.South Korea

8.3.5.1.Market size analysis, by Device Type, 2021-2031
8.3.5.2.Market size analysis, by Patient Age, 2021-2031
8.3.5.3.Market size analysis, by End User, 2021-2031

8.3.6.Rest of Asia-Pacific

8.3.6.1.Market size analysis, by Device Type, 2021-2031
8.3.6.2.Market size analysis, by Patient Age, 2021-2031
8.3.6.3.Market size analysis, by End User, 2021-2031

8.3.7.Research Dive Exclusive Insights

8.3.7.1.Market attractiveness, 2021-2031
8.3.7.2.Competition heatmap, 2021-2031

8.4.LAMEA

8.4.1.Brazil

8.4.1.1.Market size analysis, by Device Type, 2021-2031
8.4.1.2.Market size analysis, by Patient Age, 2021-2031
8.4.1.3.Market size analysis, by End User, 2021-2031

8.4.2.Saudi Arabia

8.4.2.1.Market size analysis, by Device Type, 2021-2031
8.4.2.2.Market size analysis, by Patient Age, 2021-2031
8.4.2.3.Market size analysis, by End User, 2021-2031

8.4.3.UAE

8.4.3.1.Market size analysis, by Device Type, 2021-2031
8.4.3.2.Market size analysis, by Patient Age, 2021-2031
8.4.3.3.Market size analysis, by End User, 2021-2031

8.4.4.South Africa

8.4.4.1.Market size analysis, by Device Type, 2021-2031
8.4.4.2.Market size analysis, by Patient Age, 2021-2031
8.4.4.3.Market size analysis, by End User, 2021-2031

8.4.5.Rest of LAMEA

8.4.5.1.Market size analysis, by Device Type, 2021-2031
8.4.5.2.Market size analysis, by Patient Age, 2021-2031
8.4.5.3.Market size analysis, by End User, 2021-2031

8.4.6.Research Dive Exclusive Insights

8.4.6.1.Market attractiveness, 2021-2031
8.4.6.2.Competition heatmap, 2021-2031

9.Competitive Landscape

9.1.Top winning strategies, 2021

9.1.1.By strategy
9.1.2.By year

9.2.Strategic overview

9.3.Market share analysis, 2021

10.Company Profiles

10.1. Medtronic

10.1.1.Overview
10.1.2.Business segments
10.1.3.Product portfolio
10.1.4.Financial performance
10.1.5.Recent developments
10.1.6.SWOT analysis

10.2.Smiths Medical, Inc.

10.2.1.Overview
10.2.2.Business segments
10.2.3.Product portfolio
10.2.4.Financial performance
10.2.5.Recent developments
10.2.6.SWOT analysis

10.3.Teleflex Incorporated.

10.3.1.Overview
10.3.2.Business segments
10.3.3.Product portfolio
10.3.4.Financial performance
10.3.5.Recent developments
10.3.6.SWOT analysis

10.4. KARL STORZ SE & Co. KG

10.4.1.Overview
10.4.2.Business segments
10.4.3.Product portfolio
10.4.4.Financial performance
10.4.5.Recent developments
10.4.6.SWOT analysis

10.5.Ambu A/S.

10.5.1.Overview
10.5.2.Business segments
10.5.3.Product portfolio
10.5.4.Financial performance
10.5.5.Recent developments
10.5.6.SWOT analysis

10.6.Flexicare (Group) Limited

10.6.1.Overview
10.6.2.Business segments
10.6.3.Product portfolio
10.6.4.Financial performance
10.6.5.Recent developments
10.6.6.SWOT analysis

10.7.Intersurgical Ltd

10.7.1.Overview
10.7.2.Business segments
10.7.3.Product portfolio
10.7.4.Financial performance
10.7.5.Recent developments
10.7.6.SWOT analysis

10.8.SunMed

10.8.1.Overview
10.8.2.Business segments
10.8.3.Product portfolio
10.8.4.Financial performance
10.8.5.Recent developments
10.8.6.SWOT analysis

10.9.VYAIRE MEDICAL, INC.

10.9.1.Overview
10.9.2.Business segments
10.9.3.Product portfolio
10.9.4.Financial performance
10.9.5.Recent developments
10.9.6.SWOT analysis

10.10.Vbm Medizintechnik.

10.10.1.Overview
10.10.2.Business segments
10.10.3.Product portfolio
10.10.4.Financial performance
10.10.5.Recent developments
10.10.6.SWOT analysis

11.Appendix

11.1.Parent & peer market analysis
11.2.Premium insights from industry experts
11.3.Related reports



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 左心耳 (LAA) 閉鎖デバイスのグローバル市場2022-2031：心外膜LAAデバイス、心内膜LAA閉鎖デバイス
  • 気道管理装置のグローバル市場（2021〜2031）：声門下装置、声門上装置、喉頭鏡、蘇生器、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(RDV23MA012 )"気道管理デバイスのグローバル市場2022-2031：声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他" (英文：Airway Management Devices Market by Device Type (Infraglottic Devices, Supraglottic Devices, Laryngoscopes, Resuscitators, and Others), Patient Age (Adult Patients and Pediatric Patients), and End User (Hospitals, Ambulatory Care, Home Care, and Others): Global Opportunity Analysis and Industry Forecast 2022–2031)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。